43 results on '"Snellman, Josefin"'
Search Results
2. Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study
3. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
4. Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
5. Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
6. Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
7. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab
8. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial
9. Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
10. Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
11. Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
12. Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle
13. 208 Long-term efficacy of erenumab in patients with chronic migraine who failed ≥3 prior prophylactic treatments
14. 209 Increased burden of headache in patients with migraine complicated by MOH: sub-group analysis BECOME study
15. Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
16. Additional file 1 of Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
17. Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle.
18. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches
19. Regulation of ON bipolar cell activity
20. Opening of BKCa channels causes migraine attacks
21. sj-pdf-1-cep-10.1177_0333102420981666 - Supplemental material for Hypersensitivity to calcitonin gene-related peptide in chronic migraine
22. Hypersensitivity to calcitonin gene-related peptide in chronic migraine
23. Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers
24. Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers
25. Safety and tolerability of erenumab in older migraine patients: A subgroup analysis of randomised trials (1207)
26. Switching between transient and sustained signalling at the rod bipolar-AII amacrine cell synapse of the mouse retina
27. Supplemental material for Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
28. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
29. Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries
30. Erenumab (AMG334) An Antagonist to Canonical CGRP-Receptor Does Not Impair Vasodilatory or Contractile Responses to Other Agents In Human Isolated Cerebral Arteries (S17.002)
31. Disease Management and Outcomes in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Analysis of Observational Data from the United States
32. Categorization of Hematological Responses to Oral Iptacopan Monotherapy in Anti-C5-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia in the Phase III APPLY-PNH Trial and Complement Inhibitor-Naïve Patients in the Phase III APPOINT-PNH Trial
33. Synaptic Ribbons Influence the Size and Frequency of Miniature-like Evoked Postsynaptic Currents
34. Acute Damage to Synaptic Ribbons Differentially Affects Evoked and Spontaneous Neurotransmitter Release from Rod Bipolar Cells
35. Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming
36. cGMP-Dependent Kinase Regulates Response Sensitivity of the Mouse On Bipolar Cell
37. Regulation of the Retinal Bipolar Cell mGluR6 Pathway by Calcineurin
38. Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study.
39. Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
40. Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers.
41. Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.
42. Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation.
43. Opening of BK Ca channels alters cerebral hemodynamic and causes headache in healthy volunteers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.